Algorae Pharmaceuticals Ltd (1AI) — Capital Reinvestment Ratio

Latest as of September 2013: 0.01x

Algorae Pharmaceuticals Ltd (1AI) has a Capital Reinvestment Ratio of 0.01x as of September 2013, meaning it reinvests 0% of its operating cash flow (AU$334.25K) in capital expenditures (AU$5.00K). See Algorae Pharmaceuticals Ltd (1AI) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

AU$334.25K
AUD

Capital Expenditures

AU$5.00K
AUD

Data as of

Sep 2013
Most recent filing

Algorae Pharmaceuticals Ltd Capital Reinvestment Ratio (2013–2013)

This chart tracks Algorae Pharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods. Check Algorae Pharmaceuticals Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Algorae Pharmaceuticals Ltd (2013–2013)

Year-by-year Capital Reinvestment Ratio for Algorae Pharmaceuticals Ltd from 2013 to 2013. For live market cap and broader valuation context, see 1AI market cap.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2013 0.01x AU$1.34 Million AU$20.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow